SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-242039
Filing Date
2021-08-10
Accepted
2021-08-10 17:26:08
Documents
72
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d180355d10q.htm   iXBRL 10-Q 2161278
2 EX-3.1 d180355dex31.htm EX-3.1 31627
3 EX-3.2 d180355dex32.htm EX-3.2 170625
4 EX-31.1 d180355dex311.htm EX-31.1 9687
5 EX-31.2 d180355dex312.htm EX-31.2 9742
6 EX-32.1 d180355dex321.htm EX-32.1 4362
7 EX-32.2 d180355dex322.htm EX-32.2 4413
13 GRAPHIC g180355g31b73.jpg GRAPHIC 108911
  Complete submission text file 0001193125-21-242039.txt   7080327

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA dawn-20210630.xsd EX-101.SCH 53745
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dawn-20210630_cal.xml EX-101.CAL 31803
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dawn-20210630_def.xml EX-101.DEF 262679
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20210630_lab.xml EX-101.LAB 373936
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20210630_pre.xml EX-101.PRE 341886
14 EXTRACTED XBRL INSTANCE DOCUMENT d180355d10q_htm.xml XML 739598
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40431 | Film No.: 211161157
SIC: 2834 Pharmaceutical Preparations